YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines. - Wikidata - awgldk - TriplyDB

YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.

YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.

http://www.wikidata.org/entity/Q34604733

about

The naturally occurring YMDD mutation among patients chronically infected HBV and untreated with lamivudine: a systematic review and meta-analysis Pre-existing mutations in reverse transcriptase of hepatitis B virus in treatment-naive Chinese patients with chronic hepatitis B Association between clinical features and YMDD mutations in patients with chronic hepatitis B following lamivudine therapy Hepatitis B virus genotypes circulating in Brazil: molecular characterization of genotype F isolates.Lamivudine resistance mutations in patients infected with hepatitis B virus genotype D.Prevalence and significance of Hepatitis B reverse transcriptase mutants in different disease stages of untreated patients Future prospectives for the management of chronic hepatitis B.Review article: Success and failure of nucleoside and nucleotide analogues in chronic hepatitis B.Incidence of natural resistance mutations in naïve chronic hepatitis B patients: a systematic review and meta-analysis.HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining Analysis of reverse transcriptase gene mutations in the hepatitis B virus at a university hospital in Korea.Comparison of amplicon-sequencing, pyrosequencing and real-time PCR for detection of YMDD mutants in patients with chronic hepatitis B.Hepatitis B virus reverse transcriptase mutations in treatment Naïve chronic hepatitis B patients.Comparison of ligase detection reaction and real-time PCR for detection of low abundant YMDD mutants in patients with chronic hepatitis B.Naturally occurring amino-acid substitutions to nucleos(t)ide analogues in treatment naive Turkish patients with chronic hepatitis B.Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naïve patients with chronic hepatitis B.YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay.Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression.

P2860

Q27007658-6EE33984-70FF-46AD-8580-106BBF7C8763 Q28545179-EB882A4F-B61F-4C33-85FD-3908537C1E8A Q30390865-F58BA141-C27F-4C15-8CC7-E3FB4C25EBA7 Q33307062-35AC45A5-B63E-4414-99DD-B4487DEC97B3 Q35609489-483171A7-5606-4F34-B102-AAB93428ECCD Q36295816-4955BF9B-A693-4E2D-BC92-6A3B847BECC5 Q36841719-ED6689F4-AEFB-4417-B5E0-23728C5B5C13 Q37032761-F90DE2BC-C069-440F-9AC8-06D659210351 Q38260502-63964D06-83B1-4B42-9FE2-52A76961BB8B Q38657888-2D71681E-7F4A-4285-91FE-F361D22C164C Q38960336-DF24A203-ABDE-4A88-8EE7-BFB30549E6A6 Q42177495-096EDE51-1559-4608-B41A-BBD1A13DC271 Q42278809-0D4C8A77-30E3-48D9-B9E6-AD949D94AFA5 Q43141117-CD9885D2-7A26-4E93-BB79-B4C02580D5A3 Q43813577-BC31A57B-32A0-4439-8E45-32E6D8EFDAA6 Q46175222-2E9863A3-2FA3-4295-915D-E1FE034DF580 Q54573687-B8EBCA12-6F6D-4594-893E-BC2ED7357302 Q55019535-C11BAAF3-B3EC-4B1C-98A1-76CAD392590C

P2860

YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.

http://www.wikidata.org/entity/Q34604733

description

2005 nî lūn-bûn

@nan

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.

@ast

YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.

@en

YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.

@nl

type

label

YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.

@ast

YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.

@en

YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.

@nl

prefLabel

YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.

@ast

YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.

@en

YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.

@nl

P1433

Q34604733-82DD65A1-1F12-4AC4-B341-F1719A408DD4

P1476

Q34604733-71E5373C-B24B-46B7-B23D-2C2946EB5CFA

P2093

Q34604733-289C0FDA-631D-43E9-B11C-29F5906455CD

Q34604733-2D2DCE67-327D-42CD-A052-3D826718DAF6

Q34604733-47AFD02C-C055-4BFD-AE71-3B362B540672

Q34604733-5E7CAEDA-9AE1-472F-B077-151BCB15011E

Q34604733-608E1A2A-500E-42EC-95ED-8EA29EBF22DD

Q34604733-ACF56CAD-8A50-4952-BC11-D860AE1736A4

Q34604733-BD98B383-75EB-4891-9C83-86BFEA449D1C

Q34604733-D62AC77C-9A6B-46B1-B1C9-E89E0B4D9967

P2860

Q34604733-00E67E4E-3D7A-46DE-B3D8-A2EF81820E6C

Q34604733-01099850-23E0-43C7-9490-13C4DAAFA08B

Q34604733-1025C668-78D1-427E-8648-AF9F4DD4150B

Q34604733-18260F43-DB24-4379-9135-FE683FAC103C

Q34604733-1B4A996F-32A5-4A11-ADF9-249B18528CA8

Q34604733-1E242D1B-87F4-4340-8258-E3239BC16895

Q34604733-24B425EF-182E-4805-94A4-60B4EBEE2247

Q34604733-39FE62D6-3CE3-48F1-B62B-878A65725B95

Q34604733-45DD1FB6-F67C-4D73-9F14-F0AB33493475

Q34604733-5155EF9A-1ACB-46A2-B3EE-BAED28DDD9A8

P304

Q34604733-79E93340-2C1C-4FA1-ACA8-14B7D0678888

P31

Q34604733-27AB3A9E-9974-4326-9E7C-5849CE4B735F

P356

Q34604733-03F51B0E-DF0D-4A93-AE5D-48802DB5AA1F

P407

Q34604733-197D9872-0C8F-445B-B0CE-E01E84302F99

P433

Q34604733-33ACDDCD-FF4A-4CA4-84C7-1B7C8FB26B59

P478

Q34604733-A2459D2C-4100-4455-AFEF-E9A657393F29

P577

Q34604733-50C04738-3B54-4B47-93C1-D1CAA944D2DD

P5875

Q34604733-5F8CFC87-065F-42F3-9597-783673720EEE

P698

Q34604733-AE501DD2-A6C6-411A-9C9B-DFC5ED7B5DDB

P932

Q34604733-BC04276E-1875-4944-9CDD-8F9633C4240E

P356

P1433

World Journal of Gastroenterology

P1476

YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.

@en

P2093

Hou-Ji Qin

http://www.w3.org/2001/XMLSchema#string

Mei-Jin Huang

http://www.w3.org/2001/XMLSchema#string

Qi-Wen Huang

http://www.w3.org/2001/XMLSchema#string

Xiang Xu

http://www.w3.org/2001/XMLSchema#string

Ya-Qin Qin

http://www.w3.org/2001/XMLSchema#string

Yan-Zhuan He

http://www.w3.org/2001/XMLSchema#string

Yiao-Nan Zhou

http://www.w3.org/2001/XMLSchema#string

Zhong-Min Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group

Management of viral hepatitis B.

Experience with lamivudine therapy for hepatitis B virus infection before and after liver transplantation, and review of the literature.

Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial.

Results of lamivudine trials in Asia.

Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers.

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation.

Fatal hepatic failure after emergence of the hepatitis B virus mutant during lamivudine therapy in a patient with liver cirrhosis.

Recent progress and new trends in the treatment of hepatitis B.

Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment.

P304

867-870

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V11.I6.867

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8050658

http://www.w3.org/2001/XMLSchema#string

P698

15682483

http://www.w3.org/2001/XMLSchema#string

P932

4250599

http://www.w3.org/2001/XMLSchema#string